IRMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IRMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
iRadimed's dividend payout ratio for the months ended in Mar. 2024 was 0.00.
The historical rank and industry rank for iRadimed's Dividend Payout Ratio or its related term are showing as below:
During the past 12 years, the highest Dividend Payout Ratio of iRadimed was 0.10. The lowest was 0.10. And the median was 0.10.
As of today (2024-05-16), the Dividend Yield % of iRadimed is 0.36%.
During the past 12 years, the highest Trailing Annual Dividend Yield of iRadimed was 0.37%. The lowest was 0.33%. And the median was 0.35%.
iRadimed's Dividends per Share for the months ended in Mar. 2024 was $0.00.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
The historical data trend for iRadimed's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRadimed Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Dividend Payout Ratio | Get a 7-Day Free Trial | - | - | - | - | 0.10 |
iRadimed Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Dividend Payout Ratio | Get a 7-Day Free Trial | - | - | - | 0.39 | - |
For the Medical Devices subindustry, iRadimed's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where iRadimed's Dividend Payout Ratio falls into.
Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.
iRadimed's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Dividend Payout Ratio | = | Dividends per Share (A: Dec. 2023 ) | / | EPS without NRI (A: Dec. 2023 ) |
= | 0.15 | / | 1.48 | |
= | 0.10 |
iRadimed's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as
Dividend Payout Ratio | = | Dividends per Share (Q: Mar. 2024 ) | / | EPS without NRI (Q: Mar. 2024 ) |
= | 0 | / | 0.32 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRadimed (NAS:IRMD) Dividend Payout Ratio Explanation
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thank you for viewing the detailed overview of iRadimed's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Roger E. Susi | director, 10 percent owner, officer: CEO, President, Chairman | C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708 |
James B Hawkins | director | C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708 |
Anthony Vuoto | director | |
Monty K Allen | director | |
Hilda Frederique Scharen-guivel | director | 440 PALM ISLAND SE, CLEARWATER BEACH FL 33767 |
John Glenn | officer: Chief Financial Officer | 7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577 |
Christopher K. Scott | officer: CHIEF FINANCIAL OFFICER & SECR | C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708 |
Brent Johnson | officer: Exec. VP. Sales & Marketing | 4900 HOPYARD RD, SUITE 210, PLEASITAN CA 94588 |
Steven M. Nardi | officer: VP MANUFACTURING | C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708 |
Louis S. Waldman | officer: CONTROLLER | C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708 |
Leslie L Mcdonnell | director, officer: Chief Exec Officer & Director | 1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Francis X. Casey | officer: VP OF REG AND QUAL ASSURANCE | C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708 |
John K Mccreery | officer: Chief Operating Officer | IRADIMED CORP, 1025 WILLA SPRINGS BLVD, WINTER SPRINGS FL 32708 |
Jonathan Kennedy | director | INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035 |
Serge Novovich | director | C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708 |
From GuruFocus
By GuruFocus Research • 11-14-2023
By GuruFocusNews GuruFocusNews • 07-05-2022
By PurpleRose PurpleRose • 07-29-2022
By Marketwired • 08-03-2023
By sperokesalga sperokesalga • 02-24-2023
By Marketwired • 10-26-2023
By Value_Insider Value_Insider • 10-27-2022
By GuruFocus Research GuruFocus Editor • 05-25-2023
By GuruFocusNews GuruFocusNews • 06-15-2022
By GuruFocus Research GuruFocus Editor • 01-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.